Vallejo-Cremades, Mayte
Merino, Javier
Carmona, Rita
Córdoba, Laura
Salvador, Beatriz
Martínez, Leopoldo
Tovar, Juan Antonio
Llamas, Miguel Ángel
Muñoz-Chápuli, Ramón
Fresno, Manuel https://orcid.org/0000-0002-9223-5477
Funding for this research was provided by:
Ministerio de Ciencia e Innovación (SAF2016-75988-R, PID2022-137487OB-I00)
Comunidad de Madrid (S2017/BMD-3671. INFLAMUNE-CM)
Fundación MEHUER (Ayuda Real e Ilustre Colegio Oficial de Farmaceuticos de Sevilla)
Fundación Ramón Areces (Centro de Biología Molecular Severo Ochoa)
Fundación Banco Santander (Centro d)
Article History
Received: 2 July 2024
Accepted: 23 September 2024
First Online: 18 October 2024
Declarations
:
: No human materials were used in this study, and all animal experimentation were performed in strict accordance with Spanish legislation (RD 53/2013) and European legislation (2010/63/EU). the European Commission legislation for the protection of animal. They followed ARRIVE guidelines and received approval from the Fundación para la Investigación Biomédica del Hospital Universitario La Paz ethics committee (PROEX185/15), by the Committee on the Ethics of Animal Experiments of the University of Malaga (permit code 2015–0028) and Comité de Ética de la Dirección General del Medio Ambiente de la Comunidad de Madrid, (permits PROEX 128/15).
: Not applicable.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.